GATA4 and GATA6 were previously implicated in EAC by the numerous studies that have observed that their loci are frequently amplified in the transition from Barrett's esophagus to cancer (Lin et al. 2012; Stachler et al. 2015). Here, GATA4 is linked to esophageal adenocarcinoma.